Evidence map›Paper›PMID 38296402›Full record

ArticleJournal of the American College of Cardiology2024

Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic Stenosis.

Khaled Shelbaya, Victoria Arthur, Yimin Yang, Pranav Dorbala, Leo Buckley, Brian Claggett, Hicham Skali, Line Dufresne, Ta-Yu Yang, James C Engert and 15 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics.Journal of cardiovascular development and disease · 2025
    Review
  18. Article
  19. Novel Circulating Biomarkers in Aortic Valve Stenosis.International journal of molecular sciences · 2025
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 2 countries.

Khaled ShelbayaBrigham and Women's Hospital, Boston, Massachusetts, USA.
Victoria ArthurBrigham and Women's Hospital, Boston, Massachusetts, USA.
Yimin YangBrigham and Women's Hospital, Boston, Massachusetts, USA.
Pranav DorbalaBrigham and Women's Hospital, Boston, Massachusetts, USA.
Leo BuckleyBrigham and Women's Hospital, Boston, Massachusetts, USA.
Brian ClaggettBrigham and Women's Hospital, Boston, Massachusetts, USA.
Hicham SkaliBrigham and Women's Hospital, Boston, Massachusetts, USA.
Line DufresneMcGill University Health Centre, Montreal, Quebec, Canada.
Ta-Yu YangMcGill University Health Centre, Montreal, Quebec, Canada.
James C EngertMcGill University Health Centre, Montreal, Quebec, Canada.
George ThanassoulisMcGill University Health Centre, Montreal, Quebec, Canada.
James FloydCardiovascular Health Research Unit, Seattle, Washington, USA.
Thomas R AustinCardiovascular Health Research Unit, Seattle, Washington, USA.
Anna BortnickMontefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York, USA.
Jorge KizerVeterans Affairs Medical Center, San Francisco, California, USA.
Renata C C FreitasBrigham and Women's Hospital, Boston, Massachusetts, USA.
Sasha A SinghBrigham and Women's Hospital, Boston, Massachusetts, USA.
Elena AikawaBrigham and Women's Hospital, Boston, Massachusetts, USA.
Ron C HoogeveenBaylor College of Medicine, Houston, Texas, USA.
Christie BallantyneBaylor College of Medicine, Houston, Texas, USA.
Bing YuUniversity of Texas Health Science School of Public Health, Houston, Texas, USA.
Josef CoreshJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Michael J BlahaJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Kunihiro MatsushitaJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Amil M ShahBrigham and Women's Hospital, Boston, Massachusetts, USA; University of Texas Southwestern Medical Center, Dallas, Texas, USA. Electronic address: amil.shah@utsouthwestern.edu.
Brigham and Women's Hospital · USMcGill University Health Centre · CAJohns Hopkins University · USBaylor College of Medicine · USAlbert Einstein College of Medicine · USSan Francisco VA Medical Center · USSouthwestern Medical Center · US

Funding

Mapping the Progression to HFpEF in the Elderly through Longitudinal Changes in Cardiac FunctionR01HL135008 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI Amil M Shah · 2017 to 2026
$11.5M
Plasma proteomics in CHS and population biologyR01HL144483 · NHLBI · UNIVERSITY OF WASHINGTON · PI DURDA, JON PETER, GERSZTEN, ROBERT E · 2019 to 2022
$6.0M
Improving Mitral Compensation In Ischemic RegurgitationR01HL141917 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI AIKAWA, ELENA, BISCHOFF, JOYCE E. · 2018 to 2021
$5.6M
Subclinical Atrial Fibrillation and Supraventricular Ectopy in the Jackson Heart StudyR01HL142599 · NHLBI · UNIVERSITY OF WASHINGTON · PI FLOYD, JAMES S · 2018 to 2022
$4.9M
Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late LifeR01HL150342 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DORBALA, SHARMILA, SHAH, AMIL M · 2020 to 2023
$4.1M
Quantifying cardiovascular calcification at very old age for personalized risk classificationR01HL136592 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BLAHA, MICHAEL J, MATSUSHITA, KUNIHIRO · 2017 to 2021
$3.7M
Quantifying cardiac structure and function to define the progression to hear failure in African AmericansR01HL143224 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SHAH, AMIL M · 2018 to 2021
$3.4M
Proteomic signatures to identifypathways underlying the progression toheart failureR01HL148218 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SHAH, AMIL M, YU, BING · 2020 to 2023
$3.4M
Proteomic discovery in an inception cohort of acute myocardial infarction survivorsR01HL149706 · NHLBI · UNIVERSITY OF WASHINGTON · PI FLOYD, JAMES S · 2020 to 2023
$3.0M
Contributions of pulmonary arterial and venous remodeling to HFpEF in the elderlyR01HL160025 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SAN JOSE ESTEPAR, RAUL, SHAH, AMIL M · 2022 to 2025
$3.0M
New driver of fibrosis and calcification in CAVDR01HL147095 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI AIKAWA, ELENA · 2019 to 2022
$2.4M
Molecular and Genetic Epidemiology of Lp(a)-mediated Calcific Aortic Valve DiseaseR01HL128550 · NHLBI · MCGILL UNIVERSITY HEALTH CTR RES INST · PI THANASSOULIS, GEORGE · 2017 to 2020
$1.7M
NHLBI NIH HHS HHSN268201700001CNHLBI NIH HHS HHSN268201700001INHLBI NIH HHS HHSN268201700002CNHLBI NIH HHS HHSN268201700002INHLBI NIH HHS HHSN268201700003CNHLBI NIH HHS HHSN268201700003INHLBI NIH HHS HHSN268201700004CNHLBI NIH HHS HHSN268201700004INHLBI NIH HHS HHSN268201700005CNHLBI NIH HHS HHSN268201700005INHLBI NIH HHS K23 HL146982NHLBI NIH HHS K23 HL150311NHLBI NIH HHS K24 HL152008NHLBI NIH HHS R01 HL128550NHLBI NIH HHS R01 HL135008NHLBI NIH HHS R01 HL136592NHLBI NIH HHS R01 HL141917NHLBI NIH HHS R01 HL142599NHLBI NIH HHS R01 HL143224NHLBI NIH HHS R01 HL144483NHLBI NIH HHS R01 HL147095NHLBI NIH HHS R01 HL148218NHLBI NIH HHS R01 HL149706NHLBI NIH HHS R01 HL150342NHLBI NIH HHS R01 HL160025
6 · The paper itself

Abstract

backgroundLimited data exist regarding risk factors for aortic stenosis (AS). The plasma proteome is a promising phenotype for discovery of novel biomarkers and potentially causative mechanisms.

objectivesThe aim of this study was to discover novel biomarkers with potentially causal associations with AS.

methodsWe measured 4,877 plasma proteins (SomaScan aptamer-affinity assay) among ARIC (Atherosclerosis Risk In Communities) study participants in mid-life (visit 3 [V3]; n = 11,430; age 60 ± 6 years) and in late-life (V5; n = 4,899; age 76 ± 5 years). We identified proteins cross-sectionally associated with aortic valve (AV) peak velocity (AVmax) and dimensionless index by echocardiography at V5 and with incident AV-related hospitalization after V3 with the use of multivariable linear and Cox proportional hazard regression. We assessed associations of candidate proteins with changes in AVmax over 6 years and with AV calcification with the use of cardiac computed tomography, replicated analysis in an independent sample, performed Mendelian randomization, and evaluated gene expression in explanted human AV tissue.

resultsFifty-two proteins cross-sectionally were associated with AVmax and dimensionless index at V5 and with risk of incident AV-related hospitalization after V3. Among 3,413 participants in the Cardiovascular Health Study, 6 of those proteins were significantly associated with adjudicated moderate or severe AS, including matrix metalloproteinase 12 (MMP12), complement C1q tumor necrosis factor-related protein 1 (C1QTNF1), and growth differentiation factor-15. MMP12 was also associated with greater increase in AVmax over 6 years, greater degree of AV calcification, and greater expression in calcific compared with normal or fibrotic AV tissue. C1QTNF1 had consistent potential causal effects on both AS and AVmax according to Mendelian randomization analysis.

conclusionsThese findings identify MMP12 as a potential novel circulating biomarker of AS risk and C1QTNF1 as a new putative target to prevent AS progression.

Indexed as

Aortic Valve StenosisCalcinosisProteomicsAgedAged, 80 and overAortic ValveBiomarkersHumansMatrix Metalloproteinase 12Middle AgedRisk FactorsBiomarkersMatrix Metalloproteinase 12aortic stenosisechocardiographyepidemiologyproteomics

Identifiers

PMID38296402
PMCPMC12582517
OpenAlexW4391333882

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.